Cambodia becomes the first Asia-Pacific country to reach the HIV 95-95-95 targets

What the three 95s actually measure

The first target is for 95% of people living with HIV to know their status. The second is for 95% of people who have been diagnosed to receive antiretroviral treatment. The third is for 95% of people on treatment to achieve viral suppression.

Those are sequential measures with different denominators. They do not mean that 95% of Cambodia's population has been tested, nor that every person in the country has the same route into care.

UNAIDS attributes the result to a combination of government services, community-led outreach and practical changes that made it easier for people to remain in care. Its June report points to peer counselling, more accessible testing and multi-month dispensing of antiretroviral medicines among the measures supporting treatment continuity.

For practical context, see Cambodia economy and finance. This development also connects with Battambang waste project targets 25,000 rural residents.

The milestone does not mean HIV transmission has ended

Cambodia was still estimated to have recorded 958 new HIV infections in 2025, according to figures cited in the June government report, with 84% occurring among key populations and their partners. The national goal is to bring annual new infections below 250 by 2030.

UNAIDS also warned that the achievement needs to be sustained. Community organisations remain important to outreach and treatment retention, while uncertainty around external financing creates a risk that services which helped produce the result could come under pressure.

That makes 95-95-95 a milestone in coverage, not an “end of HIV” declaration. It shows that the treatment cascade has reached the target thresholds while prevention and long-term funding still require attention.

**What long-term residents can reasonably take from the result**

UNAIDS describes HIV treatment in Cambodia as free, while also noting that travel costs, poverty and other practical barriers can still make care harder to reach. The sources behind this story do not establish one identical access pathway for every foreign resident, nor do they show that every facility offers the same services.

A prospective resident can therefore treat the milestone as evidence of a functioning national HIV programme, but not as a substitute for checking the clinic they would actually use. Eligibility, documents, location and any costs outside the treatment itself still need to be confirmed for the individual situation.